Next, we evaluated tumor development in KrasG12D;Cas9 mice transduced with sgNTC or 2 independent sgRNAs targeting Adam2. We observed that loss of Adam2 significantly reduced tumor growth and significantly extended the survival of KrasG12D mice (Fig. 3E, F and Supplementary Fig. 11c–g). This evidence concerns the gene ADAM2 and neoplasm.